Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-01-31 5:00 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 1,572,192 6.4% | 303,463 (+23.92%) | View |
| 2021-12-30 4:33 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 1,268,729 5.2% | 1,268,729 (New Position) | View |
| 2021-10-25 5:16 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Deep Track Capital LP | 1,266,884 5.18% | 1,266,884 (New Position) | View |
| 2021-09-17 4:54 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,296,452 5.3% | 1,296,452 (New Position) | View |
| 2021-06-10 11:37 am Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FMR LLC | 1,011,500 4.141% | -628,778 (-38.33%) | View |
| 2021-05-27 4:44 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | RA CAPITAL MANAGEMENT L.P. | 1,399,489 5.7% | 613,219 (+77.99%) | View |
| 2021-05-07 4:56 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Flynn James E | 1,806,037 7.43% | 1,806,037 (New Position) | View |
| 2021-02-16 4:03 pm Sale | 13D | KALVISTA PHARMACEUTICALS INC C KALV | SVLSF IV LLC | 0 0% | -1,769,576 (Position Closed) | View |
| 2021-02-16 08:31 am Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Ikarian Capital LLC | 1,063,961 5.9% | 117,356 (+12.40%) | View |
| 2021-02-12 4:30 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Vivo Ventures VI LLC | 1,383,179 5.9% | 360,686 (+35.28%) | View |
| 2021-02-08 10:25 am Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FMR LLC | 1,640,278 9.142% | -150,513 (-8.40%) | View |
| 2021-02-02 2:56 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | BlackRock Inc. BLK | 1,113,380 6.2% | 1,113,380 (New Position) | View |
| 2020-04-10 2:01 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FMR LLC | 1,790,791 10.034% | 123,813 (+7.43%) | View |
| 2020-03-23 4:28 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Ikarian Capital LLC | 946,605 5.3% | 946,605 (New Position) | View |
| 2020-02-14 4:07 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Venrock Healthcare Capital Partners II L.P. | 986,173 5.5% | -1,057,939 (-51.76%) | View |
| 2020-02-13 4:30 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Vivo Ventures VI LLC | 1,022,493 5.7% | 97,412 (+10.53%) | View |
| 2020-02-13 12:45 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Flynn James E | 0 0% | -1,217,668 (Position Closed) | View |
| 2020-02-07 11:24 am Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FMR LLC | 1,666,978 9.347% | 1,666,978 (New Position) | View |
| 2020-02-04 3:51 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | EVENTIDE ASSET MANAGEMENT LLC | 1,680,000 9.4% | 780,000 (+86.67%) | View |